A novel approach for constant rate delivery of highly soluble bioactives from a simple monolithic system.
A novel monolithic drug delivery system for highly water-soluble bioactive agents to follow pH-independent zero-order kinetics is described. The system utilizes a hydrophilic gel-based swellable polymeric material (polyethylene oxide), a model drug (metoprolol tartrate, 100% water soluble at 25 degrees C) and different electrolytes, such as sodium carbonate and/or pentasodium tripolyphosphate. Based on the induction of in situ intra-gel chemical reactions between different ionic species, drug and polymer, a heterogeneous structure manifested as 'peripheral boundary stiffening,' is accomplished. The consequence of these interactions essentially include the development of gradient-controlled matrix swelling as elucidated through textural profiling, which may contribute to inhibition of drug solubility and its outward diffusion. Analysis of textural profiles and photomicroscopy distinctly provides information on the disposition of peripheral boundary densification for the electrolyte-containing matrices. Electrolytic conductivity measurements performed with the simultaneous analysis of matrix swelling showed that sodium carbonate forms a highly reactive matrix within the first 3 h of medium penetration. On the other hand, larger molecules such as pentasodium tripolyphosphate maintain a constant conductivity level, which may be related to its lower solubility and diffusion in comparison to sodium carbonate. Based on model fitting and statistical analysis, it is shown that drug release kinetics were adequately described by M(t)/M(infinity)=k(0)t, with zero-order release rate constant k(0) of 0.054 h(-1). This novel approach in formulation development could potentially be used for constant rate delivery of highly soluble bioactive agents over an extended period for specific biopharmaceutical needs.
Pillay
V
V
School of Pharmacy, Department of Pharmaceutical Sciences, Temple University, 3307N Broad Street, Philadelphia, PA 19140, USA.
Fassihi
R
R
D002119:Calcium Carbonate; D016503:Drug Delivery Systems; D004553:Electric Conductivity; D004573:Electrolytes; D005079:Excipients; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008790:Metoprolol / Q000008:administration & dosage / Q000737:chemistry; D008970:Molecular Weight; D011092:Polyethylene Glycols; D011122:Polyphosphates; D012995:Solubility; D013607:Tablets
D004573:Electrolytes; D005079:Excipients; D011122:Polyphosphates; D013607:Tablets; D011092:Polyethylene Glycols; D008790:Metoprolol; D002119:Calcium Carbonate; C005692:triphosphoric acid